The Photopic Negative Response in Idiopathic Intracranial Hypertension

被引:29
作者
Moss, Heather E. [1 ,2 ]
Park, Jason C. [1 ]
McAnany, J. Jason [1 ]
机构
[1] Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL USA
[2] Univ Illinois, Dept Neurol & Rehabil, Chicago, IL USA
基金
美国国家卫生研究院;
关键词
photopic negative response; papilledema; retinal ganglion cells; idiopathic intracranial hypertension; VISUAL EVOKED-POTENTIALS; FLASH ELECTRORETINOGRAM; FIELD; EPIDEMIOLOGY; REDUCTION; CEREBRI;
D O I
10.1167/iovs.15-16586
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. To evaluate the photopic negative response (PhNR) as an index of retinal ganglion cell (RGC) function in idiopathic intracranial hypertension (IIH). METHODS. Amplitude and implicit time of the PhNR, as elicited by full-field, brief-luminance flashes, was measured in IIH (n = 10) and visually normal control (n = 15) subjects. Visual function was assessed in IIH subjects using standard automated perimetry mean deviation (SAP-MD) scores. Optic nerve structure was evaluated using the Frisen papilledema grading scale (FPG). Macula ganglion cell complex volume (GCCV) was extracted from optical coherence tomography images to assess RGC loss. RESULTS. Median PhNR amplitude was significantly lower in IIH subjects compared with control subjects (P = 0.015, Mann-Whitney Rank Sum [MW]), but implicit time was similar (P = 0.54, MW). In IIH subjects, PhNR amplitude and SAP-MD were correlated (Pearson's r = 0.78, P = 0.008). Ganglion cell complex volume was correlated with both SAP-MD (r = 0.72, P = 0.019) and PhNR amplitude (r = 0.77, P = 0.009). Multivariate linear regression models demonstrated that the correlation between GCCV and PhNR amplitude was improved by accounting for FPG in the model (r = 0.94, P < 0.0001), but the correlation between GCCV and SAP-MD was not (r = 0.74, P = 0.009). CONCLUSIONS. Photopic negative response amplitude, which can be decreased in IIH subjects, correlates well with a clinical measure of visual function (SAP-MD). In multivariate models, it correlated with both an imaging measure of chronic ganglion cell injury (GCCV) and a clinical measure of acute optic nerve head pathology (FPG). Further studies are needed to determine the clinical utility of PhNR as a marker for diagnosis and monitoring of IIH.
引用
收藏
页码:3709 / 3714
页数:6
相关论文
共 50 条
  • [21] Focal macular photopic negative response in patients with optic neuritis
    Nakamura, H.
    Miyamoto, K.
    Yokota, S.
    Ogino, K.
    Yoshimura, N.
    EYE, 2011, 25 (03) : 358 - 364
  • [22] An update of idiopathic intracranial hypertension
    Peralta, Gabriela Madriz
    Cestari, Dean M.
    CURRENT OPINION IN OPHTHALMOLOGY, 2018, 29 (06) : 495 - 502
  • [23] The photopic negative response (PhNR): measurement approaches and utility in glaucoma
    Prencipe, Matteo
    Perossini, Tommaso
    Brancoli, Giampaolo
    Perossini, Mario
    INTERNATIONAL OPHTHALMOLOGY, 2020, 40 (12) : 3565 - 3576
  • [24] Pediatric Idiopathic Intracranial Hypertension
    Gaier, Eric D.
    Heidary, Gena
    SEMINARS IN NEUROLOGY, 2019, 39 (06) : 704 - 710
  • [25] Time-Frequency Analysis of Photopic Negative Response in CRVO Patients
    Behbahani, Soroor
    Ramezani, Alireza
    Moridani, Mohammad Karimi
    Sabbaghi, Hamideh
    SEMINARS IN OPHTHALMOLOGY, 2020, 35 (03) : 187 - 193
  • [26] Static and pulsatile intracranial pressure in idiopathic intracranial hypertension
    Eide, Per Kristian
    Kerty, Emilia
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2011, 113 (02) : 123 - 128
  • [27] Idiopathic intracranial hypertension
    Boyter, Elizabeth
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2019, 32 (05): : 30 - 35
  • [28] Idiopathic intracranial hypertension
    Wakerley, B. R.
    Tan, M. H.
    Ting, E. Y.
    CEPHALALGIA, 2015, 35 (03) : 248 - 261
  • [29] Idiopathic Intracranial Hypertension
    Melissa W. Ko
    Current Treatment Options in Neurology, 2011, 13 : 101 - 108
  • [30] Outcomes measures in idiopathic intracranial hypertension
    Mollan, Susan P.
    Sinclair, Alexandra J.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2021, 21 (06) : 687 - 700